DK440388A - Anvendelse af eicosapentaensyre og/eller docosahexaensyre imod theumatoid arthritis - Google Patents

Anvendelse af eicosapentaensyre og/eller docosahexaensyre imod theumatoid arthritis

Info

Publication number
DK440388A
DK440388A DK440388A DK440388A DK440388A DK 440388 A DK440388 A DK 440388A DK 440388 A DK440388 A DK 440388A DK 440388 A DK440388 A DK 440388A DK 440388 A DK440388 A DK 440388A
Authority
DK
Denmark
Prior art keywords
acid
application
docosahexaic
eicosapentaic
theumatoid arthritis
Prior art date
Application number
DK440388A
Other languages
Danish (da)
English (en)
Other versions
DK440388D0 (da
Inventor
David Rubin
Original Assignee
Century Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Century Lab Inc filed Critical Century Lab Inc
Publication of DK440388D0 publication Critical patent/DK440388D0/da
Publication of DK440388A publication Critical patent/DK440388A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK440388A 1987-08-07 1988-08-05 Anvendelse af eicosapentaensyre og/eller docosahexaensyre imod theumatoid arthritis DK440388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/082,701 US4843095A (en) 1987-08-07 1987-08-07 Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis

Publications (2)

Publication Number Publication Date
DK440388D0 DK440388D0 (da) 1988-08-05
DK440388A true DK440388A (da) 1989-02-08

Family

ID=22172864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK440388A DK440388A (da) 1987-08-07 1988-08-05 Anvendelse af eicosapentaensyre og/eller docosahexaensyre imod theumatoid arthritis

Country Status (9)

Country Link
US (1) US4843095A (fi)
EP (1) EP0302482A3 (fi)
JP (1) JPS6466118A (fi)
AU (1) AU2048288A (fi)
DK (1) DK440388A (fi)
FI (1) FI883659A (fi)
HU (1) HU200686B (fi)
IL (1) IL87265A0 (fi)
ZA (1) ZA885433B (fi)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804188D0 (en) * 1988-02-23 1988-03-23 Croda Int Plc Pharmaceutical compositions
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DE69004081T2 (de) * 1990-05-23 1994-02-10 Nestle Sa Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
RU2093996C1 (ru) * 1991-01-24 1997-10-27 Мартек Корпорейшн Способ добавления в детскую питательную смесь докозагексановой кислоты и арахидоновой кислоты (варианты) и композиция (варианты)
WO1994015464A1 (en) * 1993-01-15 1994-07-21 Abbott Laboratories Structured lipids
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5411988A (en) * 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
WO1997021434A1 (en) * 1995-12-11 1997-06-19 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5972664A (en) * 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6075183A (en) * 1997-04-11 2000-06-13 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US6051754A (en) * 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US7745694B1 (en) 1997-04-11 2010-06-29 Monsanto Technology Llc Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US6136795A (en) * 1998-11-18 2000-10-24 Omni Nutraceuticals, Inc Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
WO2001051598A1 (en) 2000-01-11 2001-07-19 Monsanto Technology Llc Process for making an enriched mixture of polyunsaturated fatty acid esters
ES2386841T3 (es) * 2001-06-18 2012-09-03 Neptune Technologies & Bioressources Inc. Extractos de krill para la prevención y/o el tratamiento de enfermedades cardiovasculares
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
EP1833498B1 (en) * 2004-11-29 2010-01-27 Unilever PLC Oral composition for enhancing skin properties
US20060286199A1 (en) * 2005-06-03 2006-12-21 Marilou Laprise Method and composition for increasing omega-3 lipid in milk
US8987329B2 (en) * 2006-04-12 2015-03-24 Conopco, Inc. Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
ES2562977T3 (es) * 2006-04-12 2016-03-09 Unilever N.V. Composición oral con un efecto antienvejecimiento sobre la piel
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
DE102007055344A1 (de) * 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh Neue Verwendung von Omega-3-Fettsäure(n)
WO2010028067A1 (en) 2008-09-02 2010-03-11 Amarin Corporation Plc Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
LT3037089T (lt) 2009-02-10 2020-01-10 Amarin Pharmaceuticals Ireland Limited Eikozapentaeno rūgšties etilo esteris skirtas hipertriglicidemijai gydydti
BRPI1009431A2 (pt) * 2009-03-09 2016-03-01 Pronova Biopharma Norge As pré-concentrados farmacêuticos e de suplemento alimentar, sistemas de liberação de droga, método de tratamento de pelo menos um problema de saúde em sujeito em necessidade do mesmo e método e sistema
JP5872453B2 (ja) 2009-04-17 2016-03-01 ナタク ファルマ エセ．エレ． フィタン酸含量が低く、ω−３脂肪酸に富む組成物
LT3278665T (lt) 2009-04-29 2020-12-10 Amarin Pharmaceuticals Ireland Limited Stabili farmacinė kompozicija ir jos panaudojimo būdai
MY173994A (en) 2009-04-29 2020-03-03 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
BRPI1011883A2 (pt) 2009-06-15 2016-09-13 Amarin Pharma Inc uso de composições para redução de triglicerídeos sem elevar os níveis de o ldl-c em um paciente sob o tratamento concomitante com estatina
BR112012006692B8 (pt) 2009-09-23 2021-05-25 Amarin Corp Plc composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
KR101204748B1 (ko) * 2009-12-17 2012-11-26 (주) 켐포트 고도 불포화 지방산을 고농도로 함유하는 트리글리세라이드 유지의 제조방법
WO2011097276A1 (en) * 2010-02-02 2011-08-11 Martek Biosciences Corporation Methods and compositions for treating arthritis with docosahexaenoic acid
US20140004186A1 (en) * 2010-09-08 2014-01-02 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ778131A (en) 2010-11-29 2023-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
RU2664429C2 (ru) 2012-01-06 2018-08-17 Омтера Фармасьютикалс, Инк. Композиции омега-3 полиненасыщенных жирных кислот в форме свободной кислоты, обогащенные DPA
JP6307442B2 (ja) 2012-01-06 2018-04-04 アマリン ファーマシューティカルス アイルランド リミテッド 対象の高感度（ｈｓ−ｃｒｐ）のレベルを低下させる組成物および方法
JP6173437B2 (ja) 2012-05-07 2017-08-02 オムセラ・ファーマシューティカルズ・インコーポレイテッド スタチン及びω−３脂肪酸の組成物
DK3815684T3 (da) 2012-06-29 2024-10-21 Amarin Pharmaceuticals Ie Ltd Fremgangsmåder til at reducere risikoen for en kardiovaskulær hændelse i en person i statinbehandling
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MX2021002553A (es) 2018-09-24 2021-04-29 Amarin Pharmaceuticals Ie Ltd Metodos para reducir el riesgo de eventos cardiovasculares en un sujeto.
WO2022225896A1 (en) 2021-04-21 2022-10-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
US4472432A (en) * 1982-05-12 1984-09-18 Inabata & Co., Ltd. Medicinal use of α,β-unsaturated fatty acids
US4512996A (en) * 1982-12-13 1985-04-23 Lowell Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions

Also Published As

Publication number Publication date
IL87265A0 (en) 1988-12-30
EP0302482A3 (en) 1990-08-22
ZA885433B (en) 1989-03-29
US4843095A (en) 1989-06-27
HUT47426A (en) 1989-03-28
HU200686B (en) 1990-08-28
AU2048288A (en) 1989-02-09
JPS6466118A (en) 1989-03-13
DK440388D0 (da) 1988-08-05
EP0302482A2 (en) 1989-02-08
FI883659A0 (fi) 1988-08-05
FI883659A (fi) 1989-02-08

Similar Documents

Publication Publication Date Title
DK440388A (da) Anvendelse af eicosapentaensyre og/eller docosahexaensyre imod theumatoid arthritis
DK108987D0 (da) Karbocykliske purinnukleosider samt fremstilling og anvendelse deraf
DK33287D0 (da) Imidazolanaloge af mevalonolacton og derivater deraf
NO872772L (no) Korrosjonsresistent loddemiddel og anvendelse av dette.
DK194687A (da) Fremstilling af handsker og lignende
BR8804335A (pt) Implante oral e processo de fixar o mesmo
FI905914A0 (fi) Rikkihappomenetelmä ja laitteisto
DK193588A (da) Anvendelser af dopaminagonister
DK286288A (da) Fremgangsmaade og anlaeg til formindskelse af malegods
DK382186A (da) Materialer af polycykloalkenyl-afsluttede, umaettede polyestere eller polyesteramider og vinyl-reaktionsdygtige plastificeringsmidler dertil
DK226487A (da) Emulgeringsmiddel og emulsion indeholdende dette
NO880146L (no) Podningspolymerisator av (met)acrylsyrederivater og silikonharpikser.
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DK320288A (da) Sakkaroaskorbinsyreestere samt fremstilling og anvendelse deraf
DK675688D0 (da) Griseolsyremonoestere samt fremgangsmaade og anvendelse deraf
DK102687A (da) Fremgangsmaade til granulering af kalkpulver eller lignende
TR23973A (tr) Feniltio uereler fenilnoti uereler ve fenil karbodi- imidler bunlarin elde edilmeleri
PT82928B (pt) Processo de preparacao de 11-metilenoesteroides e das composicoes farmaceuticas que os contem
DK127187A (da) Farmaceutisk kombination af t-pa og oxypurinol
DK42688D0 (da) Acylering og sulfonering af silylketenacetaler
DK197385D0 (da) N-formyl-dithiophosphonsyreamider samt deres fremstilling og anvendelse
DK527388A (da) Farmaceutisk praeparat indeholdende en 7-diphenylmethylenbicycloheptan eller en 7-diphenylmethylenbicyclohepten samt anvendelsen af disse forbindelser og hidtil ukendte 7-diphenylmethylenbicycloheptaner og 7-diphenylmethylenbicycloheptener samt fremstillingen heraf
DK243887D0 (da) 4-alkoxy-3-pyrrolin-2-on-l-yl-eddikesyreamider samt deres fremstilling og anvendelse
NO165155C (no) Framgangsmaate for bygging og demontering av bygningsdeler.
NO854037L (no) Belegningsmiddel og anvendelse av dette.